Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Linear and branched polymer prodrugs of the water-soluble nucleoside reverse-transcriptase inhibitor emtricitabine as structural materials for long-acting implants

Journal of Materials Chemistry B(2022)10.1039/d2tb00825dSource: DataRank Database

Linear and branched polymer prodrugs of the water-soluble nucleoside reverse-transcriptase inhibitor emtricitabine as structural materials for long-acting implants is a research paper published in Journal of Materials Chemistry B (2022). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.68)OA: hybridTopics (41)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Faye Y. Hern ORCID,Chung Liu,Kartik Temburnikar,Pierre Chambon ORCID,Neill J. Liptrott ORCID

Live enrichment

PubMed:35604111 PMC:PMC9199480 OpenAlex:https://openalex.org/W4282943461

National Institutes of Health

Grant: R01AI134091-01

NIAID NIH HHS

Grant: R01 AI134091

National Institutes of Health

Grant: 5R01AI134091-05

Long acting NRTI therapies for HIV

FWCI

0.68

Citation Percentile

0.7%

Citation Trend

2023

2025

2026

hybridLicense: cc-by

journalhttps://pubs.rsc.org/en/content/articlepdf/2022/tb/d2tb00825d

publisherhttps://pubs.rsc.org/en/content/articlepdf/2022/tb/d2tb00825d

publisherhttp://pubs.rsc.org/en/content/articlepdf/2022/TB/D2TB00825D

journalhttps://doi.org/10.1039/d2tb00825d

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35604111

Fields of Study

HIV/AIDS drug development and treatmentBiochemical and Molecular ResearchPneumocystis jirovecii pneumonia detection and treatment02 engineering and technology01 natural sciences0104 chemical sciences0210 nano-technology

MeSH Terms

EmtricitabineHumansNucleosidesPolymersProdrugsDNA-Directed RNA PolymerasesWaterHIV InfectionsReverse Transcriptase InhibitorsAnti-HIV Agents

Keywords

ProdrugEmtricitabinePolymerReverse transcriptaseNucleosideChemistryMonomerDrugBiochemistryPharmacologyRNAOrganic chemistryHuman immunodeficiency virus (HIV)BiologyVirologyAnti-HIV AgentsPolymersWaterHIV InfectionsNucleosidesDNA-Directed RNA PolymerasesHumansReverse Transcriptase InhibitorsProdrugs

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Clean water and sanitation

Linear and branched polymer prodrugs of the water-soluble nucleoside reverse-transcriptase inhibitor emtricitabine as structural materials for long-acting implants

FAIR Checklist

Authors (11)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)